Preclinical and clinical data have shown that IGF-IR is overexpressed and hyper-phosphorylated in several subtypes of breast cancers (BCs) (Law et al., 2008), from which its role in BC development has stemmed. The gene discussed is IGF1R; the disease is breast cancer.